echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Hepatobiliary Surgery Department of the East Branch of the First Affiliated Hospital of Xi'an Jiaotong University successfully resected a huge liver tumor with a diameter of 25 cm

    The Hepatobiliary Surgery Department of the East Branch of the First Affiliated Hospital of Xi'an Jiaotong University successfully resected a huge liver tumor with a diameter of 25 cm

    • Last Update: 2022-01-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On January 5, the diagnosis and treatment in the Hepatobiliary Surgery Inpatient Department of the East Branch of the First Affiliated Hospital of Xi'an Jiaotong University (Yanliang District) was in order.



    After he came to the hospital, Director Sha Huanchen examined him.


    Mr.


    Director Sha Huanchen immediately submitted an application for MDT (multidisciplinary diagnosis and treatment) consultation to the Department of Hepatobiliary Surgery of the hospital.


    Therefore, Director Sha Huanchen immediately organized the surgical team to formulate a detailed surgical plan, and communicated the surgical risks with the patients and their families at the same time


    "Because there are abundant blood vessels in the human liver, the most risky risk during surgery is uncontrollable bleeding, which can lead to death or organ failure of the patient


    After perfecting the preoperative preparations, on January 5, associate professor Sha Huanchen, director of hepatobiliary surgery, and chief physician Xu Kedong, the surgical team, based on the surgical plan formulated before the operation, with the cooperation of multiple disciplines such as the anesthesia surgery department, after more than 3 hours of intense and orderly work The operation successfully completed the resection of the huge liver tumor, and the intraoperative blood loss was only 200ML


    Director Sha Huanchen once again reminded that liver cancer is a malignant tumor of the liver with insidious onset.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.